Here we report the first integrated analysis of CNAs and AI in a large cohort of HER2-amplified BC profiled by high-density genomic microarrays, allowing a comprehensive description of the genomic landscape of CNAs, amplifications, LOH and CNN-AI. This evidence concerns the gene ERBB2 and breast cancer.